All Stories

  1. Risk of bleeding in cirrhotic patients treated with rivaroxaban

    Article • Liver International, September 2017, Wiley

    Professor Juan Carlos Garcia-Pagán

  2. Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis

    Article • Hepatology, August 2017, Wiley

    Professor Juan Carlos Garcia-Pagán

  3. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

    Article • Hepatology, May 2017, Wiley

    Professor Juan Carlos Garcia-Pagán

  4. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats

    Article • Liver International, April 2017, Wiley

    Professor Juan Carlos Garcia-Pagán

  5. Reply

    Article • Hepatology, April 2017, Wiley

    Professor Juan Carlos Garcia-Pagán

  6. Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis

    Article • Hepatology, March 2016, Wiley

    Professor Juan Carlos Garcia-Pagán

  7. Nontumoral portal vein thrombosis in patients awaiting liver transplantation

    Article • Liver Transplantation, February 2016, Wiley

    Professor Juan Carlos Garcia-Pagán

  8. Reply

    Article • Hepatology, January 2016, Wiley

    Professor Juan Carlos Garcia-Pagán

  9. Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension

    Article • Liver International, October 2015, Wiley

    Professor Juan Carlos Garcia-Pagán

  10. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique

    Article • Hepatology, September 2015, Wiley

    Professor Juan Carlos Garcia-Pagán

  11. Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

    Article • Hepatology, April 2015, Wiley

    Professor Juan Carlos Garcia-Pagán, Dr Joan Genesca

  12. Thromboprophylaxis with heparin in hospitalized patients with cirrhosis: friend or foe

    Article • Liver International, July 2014, Wiley

    Professor Juan Carlos Garcia-Pagán

  13. Obeticholic acid: A new light in the shadows treating portal hypertension?

    Article • Hepatology, April 2014, Wolters Kluwer Health

    Professor Juan Carlos Garcia-Pagán

  14. Idiopathic portal hypertension: Natural history and long-term outcome

    Article • Hepatology, February 2014, Wolters Kluwer Health

    Professor Juan Carlos Garcia-Pagán

  15. Monitoring of HVPG during pharmacological therapy: Evidence in favor of the prognostic value of a 20% reduction

    Article • Hepatology, May 2004, Wiley

    Professor Juan Carlos Garcia-Pagán

  16. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

    Article • Hepatology, August 1998, Wiley

    Professor Juan Carlos Garcia-Pagán